clear space clear space clear space white space
A
 r c h i v e s   o f   M a r y l a n d   O n l i n e

PLEASE NOTE: The searchable text below was computer generated and may contain typographical errors. Numerical typos are particularly troubling. Click “View pdf” to see the original document.

  Maryland State Archives | Index | Help | Search
search for:
clear space
white space
Session Laws, 2006
Volume 750, Page 3824   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>
clear space clear space clear space white space
H.B. 1287                                               VETOES
(II) THE IDENTIFICATION AND INVESTIGATION OF UNLAWFUL
PRESCRIPTION DRUG DIVERSION; (1) (2) PROMOTE A BALANCED USE OF PRESCRIPTION MONITORING
DATA TO ASSIST APPROPRIATE LAW ENFORCEMENT ACTIVITIES WHILE PRESERVING
THE PROFESSIONAL PRACTICE OF HEALTH CARE PROVIDERS AND THE ACCESS OF
PATIENTS TO OPTIMAL PHARMACEUTICAL CARE; (2) (3) IDENTIFY THE CIRCUMSTANCES UNDER WHICH PRESCRIPTION
MONITORING DATA ARE PROVIDED TO AN AUTHORIZED RECIPIENT, WITH SUCH
CIRCUMSTANCES TO PARALLEL AS CLOSELY AS IS APPROPRIATE AN AUTHORIZED
RECIPIENT'S AUTHORITY TO ACCESS SIMILAR CONFIDENTIAL INFORMATION UNDER
CURRENT FEDERAL AND STATE LAWS AND REGULATIONS; (3) (4) IDENTIFY THE CIRCUMSTANCES UNDER WHICH AN
AUTHORIZED RECIPIENT MAY DISCLOSE PRESCRIPTION MONITORING DATA
PROVIDED BY THE PROGRAM; (4) (5) IDENTIFY THE CIRCUMSTANCES UNDER WHICH A FEDERAL
LAW ENFORCEMENT AGENCY, A STATE OR LOCAL LAW ENFORCEMENT AGENCY, OR A
LICENSING ENTITY THAT HAS RECEIVED PRESCRIPTION MONITORING DATA SHALL
CONSULT WITH THE MULTIDISCIPLINARY CONSULTATION TEAM ESTABLISHED
UNDER § 21-2A-04 OF THIS SUBTITLE ABOUT THE INTERPRETATION OF THE
PRESCRIPTION MONITORING DATA; (5) (6) PROMOTE APPROPRIATE AND REAL-TIME, IF FEASIBLE, ACCESS
TO PRESCRIPTION MONITORING DATA BY DISPENSERS AND PRESCRIBERS TO HELP
PREVENT SUBSTANCE ABUSE AND PRESCRIPTION DRUG DIVERSION; (6) IDENTIFY THE MECHANISM BY WHICH A PRESCRIPTION DRUG IS
IDENTIFIED AS A DRUG OF CONCERN; (7) REQUIRE THE BOARD TO APPLY FOR FEDERAL GRANT MONEY, AS
APPROPRIATE; (7) (8) ENSURE THAT THE PROGRAM IS DESIGNED TO: (I) MINIMIZE PREVENT, TO THE FULLEST EXTENT POSSIBLE, THE
BURDEN ON DISPENSERS IN THEIR COMPLIANCE WITH THE REQUIREMENTS OF THIS
SUBTITLE; AND (II) PROMOTE SUBMISSION OF RECEIVE PRESCRIPTION MONITORING DATA IN A MANNER COMPATIBLE WITH EXISTING DATA SUBMISSION
PRACTICES OF DISPENSERS; AND (8) (9) ENSURE, TO THE FULLEST EXTENT POSSIBLE, THAT PATIENT
CONFIDENTIALITY IS PROTECTED
ENSURE THAT: (I) CONFIDENTIAL OR PRIVILEGED PATIENT INFORMATION IS
KEPT CONFIDENTIAL; AND (II) RECORDS OR INFORMATION PROTECTED BY THE PRIVILEGE
BETWEEN A HEALTH CARE PROVIDER AND A PATIENT, OR OTHERWISE REQUIRED BY - 3824 -


 
clear space
clear space
white space

Please view image to verify text. To report an error, please contact us.
Session Laws, 2006
Volume 750, Page 3824   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>


This web site is presented for reference purposes under the doctrine of fair use. When this material is used, in whole or in part, proper citation and credit must be attributed to the Maryland State Archives. PLEASE NOTE: The site may contain material from other sources which may be under copyright. Rights assessment, and full originating source citation, is the responsibility of the user.


Tell Us What You Think About the Maryland State Archives Website!



An Archives of Maryland electronic publication.
For information contact mdlegal@mdarchives.state.md.us.

©Copyright  August 17, 2024
Maryland State Archives